MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

288 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q3 2019.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 77,664,088 shares of 93,104,451 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12,475,380 shares), BAILLIE GIFFORD & CO (9,243,803 shares), VANGUARD GROUP INC (8,650,251 shares), GLENVIEW CAPITAL MANAGEMENT, LLC (3,683,306 shares), STATE STREET CORP (3,572,866 shares), EARNEST PARTNERS LLC (3,388,249 shares), DIMENSIONAL FUND ADVISORS LP (2,951,393 shares), DISCIPLINED GROWTH INVESTORS INC /MN (2,782,027 shares), D. E. Shaw & Co., Inc. (2,503,769 shares), and NORTHERN TRUST CORP (1,896,815 shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.